Picture of Zylox-Tonbridge Medical Technology Co logo

2190 Zylox-Tonbridge Medical Technology Co Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Zylox-Tonbridge Medical Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line-100-200-114-78.7
Depreciation
Amortisation
Non-Cash Items22.455.9-5.8416
Unusual Items
Other Non-Cash Items
Changes in Working Capital-13.914.21.8125
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-82.3-116-91.398.4
Capital Expenditures-45.1-89.6-145-191
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-204-1,23950.2-15.3
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-249-1,328-95-206
Financing Cash Flow Items336399-0.722-1.25
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3462,810-30.3-11.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash13.41,359-213-119